These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 26048988)
1. Dopamine Transporter Activity Is Modulated by α-synuclein. Butler B; Goodwin S; Saha K; Becker J; Sambo D; Davari P; Khoshbouei H J Biol Chem; 2015 Jun; ():. PubMed ID: 26048988 [TBL] [Abstract][Full Text] [Related]
2. Dopamine Transporter Activity Is Modulated by α-Synuclein. Butler B; Saha K; Rana T; Becker JP; Sambo D; Davari P; Goodwin JS; Khoshbouei H J Biol Chem; 2015 Dec; 290(49):29542-54. PubMed ID: 26442590 [TBL] [Abstract][Full Text] [Related]
3. α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. Swant J; Goodwin JS; North A; Ali AA; Gamble-George J; Chirwa S; Khoshbouei H J Biol Chem; 2011 Dec; 286(51):43933-43943. PubMed ID: 21990355 [TBL] [Abstract][Full Text] [Related]
4. Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. Wersinger C; Prou D; Vernier P; Sidhu A FASEB J; 2003 Nov; 17(14):2151-3. PubMed ID: 12958153 [TBL] [Abstract][Full Text] [Related]
5. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Wersinger C; Sidhu A Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085 [TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146 [TBL] [Abstract][Full Text] [Related]
7. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991 [TBL] [Abstract][Full Text] [Related]
8. Amphetamine induces dopamine efflux through a dopamine transporter channel. Kahlig KM; Binda F; Khoshbouei H; Blakely RD; McMahon DG; Javitch JA; Galli A Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3495-500. PubMed ID: 15728379 [TBL] [Abstract][Full Text] [Related]
9. Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity. Moszczynska A; Saleh J; Zhang H; Vukusic B; Lee FJ; Liu F J Mol Neurosci; 2007; 32(3):217-27. PubMed ID: 17873367 [TBL] [Abstract][Full Text] [Related]
10. Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis/dependence. Kobayashi H; Ide S; Hasegawa J; Ujike H; Sekine Y; Ozaki N; Inada T; Harano M; Komiyama T; Yamada M; Iyo M; Shen HW; Ikeda K; Sora I Ann N Y Acad Sci; 2004 Oct; 1025():325-34. PubMed ID: 15542733 [TBL] [Abstract][Full Text] [Related]
12. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321 [TBL] [Abstract][Full Text] [Related]
13. Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol. Threlfell S; Mohammadi AS; Ryan BJ; Connor-Robson N; Platt NJ; Anand R; Serres F; Sharp T; Bengoa-Vergniory N; Wade-Martins R; Ewing A; Cragg SJ; Brimblecombe KR Front Cell Neurosci; 2021; 15():658244. PubMed ID: 33935654 [TBL] [Abstract][Full Text] [Related]
14. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305 [TBL] [Abstract][Full Text] [Related]
15. Silencing of Lanzo A; Safratowich BD; Kudumala SR; Gallotta I; Zampi G; Di Schiavi E; Carvelli L Front Physiol; 2018; 9():576. PubMed ID: 29872404 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884 [TBL] [Abstract][Full Text] [Related]
17. Rapid regulation of the dopamine transporter: role in stimulant addiction? Zahniser NR; Sorkin A Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127 [TBL] [Abstract][Full Text] [Related]
18. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant. Wersinger C; Vernier P; Sidhu A Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560 [TBL] [Abstract][Full Text] [Related]
19. Identification of Critical Residues in the Carboxy Terminus of the Dopamine Transporter Involved in the G Protein βγ-Induced Dopamine Efflux. Pino JA; Nuñez-Vivanco G; Hidalgo G; Reyes Parada M; Khoshbouei H; Torres GE Front Pharmacol; 2021; 12():642881. PubMed ID: 33841159 [TBL] [Abstract][Full Text] [Related]
20. [The dopamine transporter: characterization and physiopathologic implications]. Thibaut F; Vaugeois JM; Petit M Encephale; 1995; 21(6):445-51. PubMed ID: 8674469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]